Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Vertex Pharmaceutic (VRTX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 38,163,404
  • Shares Outstanding, K 252,120
  • Annual Sales, $ 1,702 M
  • Annual Income, $ -112,050 K
  • 36-Month Beta 1.77
  • Price/Sales 22.62
  • Price/Cash Flow 1,087.11
  • Price/Book 20.62

Price Performance

See More
Period Period Low Period High Performance
1-Month
127.67 +18.50%
on 07/18/17
167.85 -9.87%
on 07/25/17
+22.08 (+17.09%)
since 07/17/17
3-Month
115.10 +31.44%
on 05/24/17
167.85 -9.87%
on 07/25/17
+36.91 (+32.27%)
since 05/17/17
52-Week
71.46 +111.71%
on 12/22/16
167.85 -9.87%
on 07/25/17
+51.40 (+51.46%)
since 08/17/16

Most Recent Stories

More News
Biotech Stock Roundup: Regeneron Drops RSV Antibody, Gilead HIV Drug Gets Priority Review

This week, companies like Regeneron (REGN) and Ionis provided updates on their pipeline while Gilead announced priority review for its HIV drug.

CELG : 129.49 (-1.35%)
VRTX : 150.46 (-0.60%)
OPHT : 2.82 (+0.71%)
IONS : 48.53 (+2.36%)
GILD : 72.52 (-1.13%)
REGN : 468.04 (-0.11%)
GLPG : 87.98 (+0.43%)
Vertex Pharm Up 96.5% Since SmarTrend Uptrend Call (VRTX)

SmarTrend identified an Uptrend for Vertex Pharm (NASDAQ:VRTX) on January 6th, 2017 at $78.63. In approximately 7 months, Vertex Pharm has returned 96.48% as of today's recent price of $154.49.

VRTX : 150.46 (-0.60%)
After Yesterday's Decline of 2.18%, Vertex Pharm Offers Investors Better Value

Vertex Pharm (NASDAQ:VRTX) traded in a range yesterday that spanned from a low of $148.88 to a high of $152.04. Yesterday, the shares fell 2.2%, which took the trading range below the 3-day low of $152.19...

VRTX : 150.46 (-0.60%)
Biotech Stock Roundup: Q2 Earnings from Regeneron, Kite & More, FibroGen Up on IPF Data

Regeneron (REGN) and several other biotech companies reported Q2 earnings while FibroGen hit a 52-week high on promising idiopathic pulmonary fibrosis (IPF) data.

CELG : 129.49 (-1.35%)
VRTX : 150.46 (-0.60%)
DVAX : 16.55 (-0.60%)
FGEN : 40.65 (-0.25%)
ABBV : 70.30 (-0.17%)
REGN : 468.04 (-0.11%)
KITE : 128.53 (+0.34%)
Breakfast Technical Briefing on Biotech Stocks -- Sarepta Therapeutics, Trevena, Tesaro, and Vertex Pharma

If you want a Stock Review on SRPT, TRVN, TSRO, or VRTX then come over to http://dailystocktracker.com/register/ and sign up for your free customized report today. DailyStockTracker.com has issued research...

TRVN : 2.43 (+1.67%)
SRPT : 37.47 (+0.11%)
VRTX : 150.46 (-0.60%)
TSRO : 114.29 (+1.15%)
Biotech Stock Roundup: Q2 Earnings from Gilead, CELG & More, Dynavax Up on Panel Vote

Companies like Gilead (GILD) topped expectations in the second quarter while Dynavax shot up on a positive FDA advisory panel vote.

AGIO : 55.99 (-0.41%)
CELG : 129.49 (-1.35%)
VRTX : 150.46 (-0.60%)
DVAX : 16.55 (-0.60%)
ABBV : 70.30 (-0.17%)
GILD : 72.52 (-1.13%)
AMGN : 169.41 (-1.16%)
Chopping Through the Amazon Report

Chopping Through the Amazon Report

PARR : 17.05 (+0.29%)
CSTM : 10.27 (+0.69%)
HDSN : 8.59 (-0.12%)
SPXL : 35.63 (-1.27%)
WDC : 84.57 (-1.49%)
VRTX : 150.46 (-0.60%)
ALGN : 172.87 (-3.13%)
AAN : 44.27 (-1.62%)
Pharma Stocks to Watch for Earnings on Jul 28: ABBV, MRK

Total earnings for these 171 index members were up 8.8% from the year-ago quarter on a 3.4% improvement in revenues. Let's see how things are shaping up for the announcements.

MRK : 62.55 (-0.24%)
LLY : 78.52 (-2.69%)
VRTX : 150.46 (-0.60%)
ABBV : 70.30 (-0.17%)
AMGN : 169.41 (-1.16%)
GSK : 39.41 (+0.43%)
BIIB : 289.57 (-1.53%)
Zacks.com featured highlights: Farmers & Merchants Bancorp, Advanced Energy Industries, NVR, Vertex Pharmaceuticals and Sanderson Farms

Zacks.com featured highlights: Farmers & Merchants Bancorp, Advanced Energy Industries, NVR, Vertex Pharmaceuticals and Sanderson Farms

AEIS : 71.80 (-0.88%)
SAFM : 142.59 (-0.77%)
FMAO : 55.75 (+0.38%)
VRTX : 150.46 (-0.60%)
NVR : 2,759.00 (-0.04%)
Vertex (VRTX) Q2 Earnings Top on Solid Cystic Fibrosis Sales

Vertex Pharmaceuticals Incorporated's (VRTX) Q2 results were encouraging, as it topped earnings and revenues expectations backed by higher sales of both its CF drugs.

CNCE : 14.43 (-0.41%)
VRTX : 150.46 (-0.60%)
ABBV : 70.30 (-0.17%)
GLPG : 87.98 (+0.43%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More

Business Summary

Vertex Pharmaceuticals Inc. discovers, develops and markets small molecule drugs that address major unmet medical needs. The company has eight drug candidates in clinical development to treat viral diseases, inflammation, cancer, autoimmune diseases and neurological disorders. Vertex has created its...

See More

Support & Resistance

2nd Resistance Point 154.60
1st Resistance Point 152.99
Last Price 150.46
1st Support Level 150.03
2nd Support Level 148.69

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.